This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Title: Innovations by Shawn M Hillier in Cancer Treatment
Introduction
Shawn M Hillier is a notable inventor based in Boston, MA, who has made significant contributions to the field of cancer treatment. With a focus on innovative methods for combating proliferative diseases, he holds 2 patents that showcase his expertise and dedication to advancing medical science.
Latest Patents
One of Shawn's latest patents is a method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors. This patent describes methods of treating a proliferative disease in a subject by administering a DNA-damaging agent and, between about 8 and about 48 hours later, administering a DNA-PK inhibitor. The patent outlines exemplary DNA-PK inhibitors represented by specific formulas and their pharmaceutically acceptable salts.
Career Highlights
Shawn M Hillier is currently employed at Vertex Pharmaceuticals, Inc., where he continues to work on groundbreaking research in the field of oncology. His innovative approaches have the potential to change the landscape of cancer treatment and improve patient outcomes.
Collaborations
Shawn collaborates with talented coworkers, including Diane M Boucher and Wanjung Tsai, who contribute to the research and development of new therapeutic methods.
Conclusion
Shawn M Hillier's work exemplifies the spirit of innovation in the medical field, particularly in cancer treatment. His patents reflect a commitment to finding effective solutions for challenging health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile